Clinical Trials Sponsored by S&T Biomed Co., Ltd.

Total 151 results

S&T Biomed Co., Ltd.

Completed

Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer

Oral Squamous Cell Carcinoma

Taiwan
Beijing Bozhiyin T&S Co., Ltd.

Unknown

A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke

Stroke
Beijing Bozhiyin T&S Co., Ltd.

Unknown

Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)

Postoperative Ileus

China
Beijing Bozhiyin T&S Co., Ltd.

Unknown

To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats

Atrial Premature Beats

China
Beijing Bozhiyin T&S Co., Ltd.

Unknown

the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery. (Danhong)

Myocardial Infarction
Luye Pharma Group Ltd.
Beijing Bozhiyin T&S Co., Ltd.

Completed

A Study of LY03003 in Patients With Early-stage Parkinson's Disease

Parkinson Disease
Luye Pharma Group Ltd.
Beijing Bozhiyin T&S Co., Ltd.

Completed

A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease

Parkinson Disease

China
OrienGene Biotechnology Ltd.
Beijing Bozhiyin T&S Co., Ltd.; START Shanghai

Completed

A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer

Melanoma | Pancreatic Cancer | Lung Cancer | Liver Cancer

China
T&R Biofab Co., Ltd.

Unknown

A Clinical Study to Evaluate the Safety and Efficacy of Surgical Material for Nasal Septoplasty

Nasal Obstruction | Septal Deformity

Korea, Republic of
T-ACE Medical Co., Ltd

Recruiting

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan
T&R Biofab Co., Ltd.

Unknown

Clinical Extend Study to Evaluate Safety and Effectiveness of TnR Nasal Mesh for Correction of Nasal Septum on Patients

Nasal Obstruction | Septal Deformity
UnicoCell Biomed CO. LTD

Recruiting

Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis

Knee Osteoarthritis

Taiwan
CAR-T (Shanghai) Biotechnology Co., Ltd.

Completed

Stem Cells From Human Exfoliated Teeth in Treatment of Type 2 Diabetes

Type2 Diabetes

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
CAR-T (Shanghai) Biotechnology Co., Ltd.

Not yet recruiting

Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression

Depression
CAR-T (Shanghai) Biotechnology Co., Ltd.

Unknown

Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells

COVID-19
CAR-T (Shanghai) Biotechnology Co., Ltd.

Unknown

Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis

Knee Osteoarthritis

China
CAR-T (Shanghai) Biotechnology Co., Ltd.

Unknown

Stem Cells From Human Exfoliated Teeth in Treatment of Diabetic Patients With Significantly Reduced Islet Function

Type1diabetes

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Assessment of Anti-RANKL Antibody in Post-menopausal Women

Osteoporosis

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-Related Macular Degeneration

China
Jiangsu T-Mab Biopharma Co.,Ltd

Completed

Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects

Chemotherapy-induced Neutropenia

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

Chemotherapy-induced Neutropenia

China
Jiangsu T-Mab Biopharma Co.,Ltd

Completed

Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors

Chemotherapy-induced Neutropenia | Metastatic Tumors

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases

Breast Cancer
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases

Breast Cancer

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors

Solid Tumors
MiCo BioMed Co., Ltd.
Syntactx

Completed

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

SARS-CoV2 Infection

United States
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Healthy Chinese Volunteers

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Trial of HBM9378 in Healthy Chinese Subjects

Asthma

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Solid Tumor
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients (MG)

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Primary Immune Thrombocytopenic Purpura

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study of HBM9161 in NMOSD Patients

NMO Spectrum Disorder

China
Shanghai Belief-Delivery BioMed Co., Ltd

Active, not recruiting

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Hemophilia B

China
BrosMed Medical Co., Ltd

Completed

Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI

Patients With Atherosclerotic Plaques in the Coronary Arteries That Require Excision

China
BrosMed Medical Co., Ltd

Completed

Wedge NC - Scoring Balloon Dilatation Catheter

Coronary Artery Disease

China
BrosMed Medical Co., Ltd

Completed

Evaluate Safety and Efficacy of Pronavi Microcatheter for Use in Endovascular Interventions

Coronary Artery Disease | Peripheral Arterial Disease

China
BrosMed Medical Co., Ltd

Completed

Evaluate Safety and Efficacy of Alveo HP Balloon Dilatation Catheter for Balloon Dilatation of Coronary Artery Stenosis

Coronary Artery Disease

China
Biogen
Eisai Co., Ltd.

Completed

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

Healthy Volunteers

United States
S-Infinity Pharmaceuticals Co., Ltd

Recruiting

A Phase I Study of XH-S002 in Healthy Volunteers

Healthy Adults

China
S-Infinity Pharmaceuticals Co., Ltd

Recruiting

A Phase 1 Study of XH-S003 in Healthy Volunteers

Healthy

Australia
Rise Biopharmaceuticals, Inc.
T-TOP Clinical Research Co., Ltd.

Recruiting

RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

Pancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Non-resectable

Taiwan
S-Infinity Pharmaceuticals Co., Ltd

Not yet recruiting

A Phase I Study of XH-S003 in Healthy Volunteers

Healthy Adults

China

3

Subscribe